Etoposide 20mg/ml Concentrate for solution for infusion (1000mg/50ml) Malta - English - Medicines Authority

etoposide 20mg/ml concentrate for solution for infusion (1000mg/50ml)

accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents

ETOPOSIDE EBEWE etoposide 1000 mg/50 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

etoposide ebewe etoposide 1000 mg/50 ml injection vial

sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: citric acid; ethanol; benzyl alcohol; macrogol 300; polysorbate 80 - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.

ETOPOSIDE EBEWE etoposide 400 mg/20 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

etoposide ebewe etoposide 400 mg/20 ml injection vial

sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: macrogol 300; benzyl alcohol; polysorbate 80; ethanol; citric acid - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.

ETOPOSIDE EBEWE etoposide 200 mg/10 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

etoposide ebewe etoposide 200 mg/10 ml injection vial

sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: citric acid; ethanol; macrogol 300; polysorbate 80; benzyl alcohol - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.

ETOPOSIDE EBEWE etoposide 50 mg/2.5 mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

etoposide ebewe etoposide 50 mg/2.5 ml injection vial

sandoz pty ltd - etoposide, quantity: 20 mg/ml - injection, concentrated - excipient ingredients: polysorbate 80; ethanol; benzyl alcohol; macrogol 300; citric acid - small cell carcinoma of the lung. acute monocytic and myelomonocytic leukaemia; hodgkin's disease non-hodgkin's lymphoma.

ETOPOSIDE Ireland - English - HPRA (Health Products Regulatory Authority)

etoposide

accord healthcare limited - etoposide - concentrate for soln for inf - 20 mg/ml - etoposide

Etoposide 20 mg/ml concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

etoposide 20 mg/ml concentrate for solution for infusion

fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide

Etoposide 20mg/ml Concentrate for solution for Infusion (100mg/5ml vial) Malta - English - Medicines Authority

etoposide 20mg/ml concentrate for solution for infusion (100mg/5ml vial)

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Etoposide 20mg/ml concentrate for solutionn for infusion (5ml vial) Malta - English - Medicines Authority

etoposide 20mg/ml concentrate for solutionn for infusion (5ml vial)

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents

Etoposide 20mg/ml concentrate for solutionn for infusion (10ml vial) Malta - English - Medicines Authority

etoposide 20mg/ml concentrate for solutionn for infusion (10ml vial)

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - antineoplastic agents